RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform
RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms…
Arboretum_JDSeptember 9, 2021